Abortion activists are pushing to de-regulate abortion drugs at the expense of women’s safety and unborn babies’ lives.
Research published in the Journal of American Physicians and Surgeons this winter indicates that drug-induced abortions have a complication rate four times higher than surgical abortions.
“Physicians who seek to advocate for their female patients’ best interests should become aware that medical abortion results in complications far more often than its proponents acknowledge,” wrote Dr. Ingrid Skop, M.D., a San Antonio obstetrician.
Skop said abortion providers are encouraging women to choose drug-induced abortions, which involve a combination of the drugs mifepristone (Mifeprex or RU486) and misoprostol (Cytotec). They are used to abort unborn babies up to 10 weeks of pregnancy in America.
Currently, about 39 percent of abortions in the U.S. are drug-induced, according to Skop’s research.
Though safety regulations require that a doctor prescribe the drugs, the abortion industry sometimes skirts the requirement by using webcams to remotely dispense them. The method is cheaper for the abortion industry, but women never actually see a doctor in person before taking the drugs.
According to the research, risks include ruptured ectopic pregnancies, hemorrhage, infection and retained pregnancy tissue, which require surgery in as many as one in 20 women. The FDA reports at least 24 women have died along with their unborn babies from the drugs, and thousands more have been injured. In total, the number of adverse events from 2000 to 2018 is now 24 deaths, 97 ectopic pregnancies, 1,042 hospitalizations, 599 blood transfusions, and 412 infections (including 69 severe infections), with a total of 4,195 adverse events reported, according to the FDA.
Abortion activists claim the drugs are very safe, but Skop said the little research on their safety is “heavily biased.” She said only 28 states require abortion facilities to report complications.
HELP LIFENEWS SAVE BABIES FROM ABORTION! Please help LifeNews.com with a year-end donation!
“Vocal abortion advocates are aggressively using the court systems and pro-choice media sources to advocate for removal of safety restrictions on abortions,” Skop wrote. “They have also begun to advocate for illegal use of mifepristone and misoprostol when restrictions are in place, despite the demonstrated increase in adverse events that occur when these medications are used without close medical supervision.”
This includes lobbying for mail-order abortion drugs, telemedicine and abortions performed by non-physicians. California recently mandated that the abortion drugs be provided on all public college campuses, and the New York legislature is considering a similar proposal.
Meanwhile, Democrat presidential candidates Elizabeth Warren and Pete Buttigieg recently said they would allow the abortion drugs to be sold over the counter.
The ACLU also is suing the FDA and U.S. Department of Health and Human Services in a case that could force every pharmacy in America to dispense abortion drugs.
De-regulating abortion drugs also would make women and their unborn babies more vulnerable to abuse. Already, LifeNews has reported on several cases of forced abortions or abortion attempts by men who did not want their partners to have the baby.
Last week, police arrested a California man for allegedly forcing his girlfriend at gunpoint to take abortion drugs to kill their unborn child.
In 2018, a Virginia doctor was convicted of spiking his pregnant girlfriend’s drink with an abortion drug, killing their unborn baby.
In the fall, the pro-abortion news site Mother Jones reported on a similar incident. According to the report, federal authorities caught a New York City woman selling abortion drugs online after a Wisconsin man allegedly bought drugs from her and then secretly slipped them into a pregnant woman’s drink. Both the man and the seller are facing charges.
Skop concluded her report by urging doctors to be aware of the biased information coming out of the abortion industry and to consider their patients’ safety.
